baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Karyopharm Therapeutics Inc/ US48576U1060 /

2024-04-25 9:16:45 PM	Chg. -0.0100	Volume	Bid9:16:56 PM	Ask9:16:56 PM	High	Low
1.0800USD	-0.92%	503,356 Turnover: 505,929.4005	1.0800Bid Size: 1,600	1.0900Ask Size: 1,500	1.1000	1.0300

GlobeNewswire 2:45 PM International Myeloma Foundation Holds 15th Annual Gala at the Edison Ballroom in New York City on A...

GlobeNewswire 04-04 Over 52 Million Myeloma Warriors Reached, Creating Ripples Across the Globe for #MyelomaACTIONMonth

GlobeNewswire 03-21 CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors

GlobeNewswire 02-27 International Myeloma Foundation (IMF) Launches #MyelomaActionMonth for 2024 March Myeloma Action Mo...

GlobeNewswire 2023-08-24 The International Myeloma Foundation (IMF) Amplifies #kNOwMyeloma Campaign for Blood Cancer Awarenes...

Newsfile Corp 2023-05-24 FORUS Therapeutics Inc et l'Alliance pancanadienne pharmaceutique (APP) ont achevé les négociations ...

Newsfile Corp 2023-05-24 FORUS Therapeutics Inc and the Pan-Canadian Pharmaceutical Alliance (pCPA) Complete Negotiations for...

GlobeNewswire 2022-03-21 Crinetics Pharmaceuticals Appoints Chris Robillard as Chief Business Officer

GlobeNewswire 2021-12-03 Michael Falvey joins COMPASS Pathways as Chief Financial Officer

GlobeNewswire 2021-12-02 Replimune Appoints Christy Oliger to its Board of Directors

GlobeNewswire 2021-11-18 Adicet Announces Appointment of Dr. Michael G. Kauffman to the Board of Directors

GlobeNewswire 2021-08-05 Intellia Therapeutics Announces Second Quarter 2021 Financial Results and Highlights Recent Company ...

GlobeNewswire 2021-05-10 Replimune Appoints Tanya Lewis as Chief Development Operations Officer

GlobeNewswire 2021-04-15 Reata Announces the Appointments of Christy J. Oliger and Shamim Ruff to Its Board of Directors

GlobeNewswire 2021-02-17 Medical Writing Landscape Advancement Summit Provides Unique Learning Opportunities to Improve Conte...

GlobeNewswire 2020-10-19 Replimune Appoints Tanya Lewis to the Board of Directors

GlobeNewswire 2020-07-20 U.S. Food and Drug Administration Accepts Karyopharm’s Supplemental New Drug Application for XPOVIO®...

GlobeNewswire 2020-07-17 Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO® (selinexor) Res...

GlobeNewswire 2020-07-14 Calithera Biosciences Appoints Scott Garland to Board of Directors

GlobeNewswire 2020-07-14 Karyopharm Announces Preliminary Unaudited Second Quarter Product Sales for XPOVIO® (selinexor)

GlobeNewswire 2020-07-01 Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 2020-06-29 North Sur Resources and Mindset Pharma Announce Proposed Transaction to Accelerate Development of Me...

GlobeNewswire 2020-06-24 Karyopharm Announces Publication of XPOVIO® (Selinexor) Phase 2b SADAL Study Results in The Lancet H...

GlobeNewswire 2020-06-22 Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed...

GlobeNewswire 2020-06-12 Karyopharm Presents XPOVIO® (selinexor) and Eltanexor Data at the European Hematology Association 20...

Karyopharm Therapeutics Inc/ US48576U1060 /

If you wish to receive reply to your feedback, please provide your email address.